Journal ArticleOPEN ACCESS

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75

  • Takashita E
  • Yamayoshi S
  • Fukushi S
  • et al.
New England Journal of Medicine (2022) 387(13) 1236-1238
DOI: 10.1056/nejmc2209952
31Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Antibodies and Antivirals against Omicron BA.2.75 In vitro assessment of the susceptibility of BA.2.75 to approved antibodies and antivirals showed neutralizing efficacy by bebtelovimab and tixagev...

Cite

CITATION STYLE

APA

Takashita, E., Yamayoshi, S., Fukushi, S., Suzuki, T., Maeda, K., Sakai-Tagawa, Y., … Kawaoka, Y. (2022). Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75. New England Journal of Medicine, 387(13), 1236–1238. https://doi.org/10.1056/nejmc2209952

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free